ONTX

Onconova Therapeutics, Inc.

0.70 USD

Last updated Dec 6, 16:42 UTC

Yesterday HIGH

$0.7

Yesterday LOW

$0.66

52w HIGH

$1.49

52w LOW

$0.55

EPS

-0.23

PE

-3.02

Next Earnings

Mar 14, 2024

Overview News Government Trades

Onconova Therapeutics, Inc. stock is up 8.66% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 18.18% of the previous 10 December’s closed higher than November.

Benzinga Insights

Fri May 12, 2023

Earnings Outlook For Onconova Therapeutics
Benzinga Newsdesk

Thu May 11, 2023

Onconova Therapeutics Has Dosed The First Patient Phase 1/2A Trial Of Narazaciclib Combined With Letrozole In Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer. Preliminary Data From Phase 1 Portion Are Expected In 4Q 2023
Benzinga Insights

Mon Apr 24, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Lisa Levin

Fri Apr 21, 2023

Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also fell, dropping, 0.02% to 4,129.12.
Benzinga Insights

Fri Apr 21, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Lisa Levin

Fri Apr 21, 2023

Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Lisa Levin

Fri Apr 21, 2023

Gold Down Over 1%; US Composite PMI Rises In April

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 70 points on Friday. The Dow traded down 0.20% to 33,718.74 while the NASDAQ fell 0.33% to 12,019.40. The S&P 500, also fell, dropping, 0.24% to 4,119.79.
Benzinga Insights

Fri Apr 21, 2023

Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
Benzinga Insights

Fri Apr 21, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session
richadhand@benzinga.com

Fri Apr 21, 2023

HC Wainwright & Co. Upgrades Onconova Therapeutics to Buy, Announces $11 Price Target

HC Wainwright & Co. analyst Joseph Pantginis upgrades Onconova Therapeutics (NASDAQ:ONTX) from Neutral to Buy and announces $11 price target.

AFRM $40.78 USD

MDB $405.28 USD

GOOGL $131.27 USD

RIVN $19.10 USD